ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3023% above fair value
$1351.12−31.63 (-2.29%)
Close on Nov 19, 2026Market cap $1.27TP/E 43.9Yield 0.46%
Eli Lilly shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Eli Lilly's shares outstanding was 893M at Sep 30, 2026. For fiscal 2025 it was 899M, down 0.5% from the year before. Over ten years it grew -1.7% a year on average. The highest annual figure on record is 1.12B in fiscal 2012.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 899M | -0.5% |
| FY2024 | Dec 31, 2024 | 904M | +0.1% |
| FY2023 | Dec 31, 2023 | 903M | -0.1% |
| FY2022 | Dec 31, 2022 | 905M | -0.8% |
| FY2021 | Dec 31, 2021 | 912M | -0.1% |
| FY2020 | Dec 31, 2020 | 913M | -2.5% |
| FY2019 | Dec 31, 2019 | 936M | -9.5% |
| FY2018 | Dec 31, 2018 | 1.03B | -1.7% |
| FY2017 | Dec 31, 2017 | 1.05B | -0.9% |
| FY2016 | Dec 31, 2016 | 1.06B | -0.4% |
| FY2015 | Dec 31, 2015 | 1.07B | -0.8% |
| FY2014 | Dec 31, 2014 | 1.07B | -1.0% |
| FY2013 | Dec 31, 2013 | 1.08B | -2.9% |
| FY2012 | Dec 31, 2012 | 1.12B | +0.3% |
| FY2011 | Dec 31, 2011 | 1.11B | +0.7% |
| FY2010 | Dec 31, 2010 | 1.11B | +0.7% |
| FY2009 | Dec 31, 2009 | 1.10B | +0.4% |
| FY2008 | Dec 31, 2008 | 1.09B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 893M | -0.6% |
| Q2 FY2026 | Jun 30, 2026 | 894M | -0.7% |
| Q1 FY2026 | Mar 31, 2026 | 896M | -0.5% |
| Q4 FY2025 | Dec 31, 2025 | 898M | -0.6% |
| Q3 FY2025 | Sep 30, 2025 | 899M | -0.7% |
| Q2 FY2025 | Jun 30, 2025 | 900M | -0.5% |
| Q1 FY2025 | Mar 31, 2025 | 901M | -0.4% |
| Q4 FY2024 | Dec 31, 2024 | 903M | -0.1% |
| Q3 FY2024 | Sep 30, 2024 | 905M | +0.6% |
| Q2 FY2024 | Jun 30, 2024 | 904M | +0.2% |
| Q1 FY2024 | Mar 31, 2024 | 904M | +0.1% |
| Q4 FY2023 | Dec 31, 2023 | 904M | -0.1% |
| Q3 FY2023 | Sep 30, 2023 | 900M | -0.4% |
| Q2 FY2023 | Jun 30, 2023 | 903M | -0.0% |
| Q1 FY2023 | Mar 31, 2023 | 903M | -0.3% |
| Q4 FY2022 | Dec 31, 2022 | 905M | -0.7% |
| Q3 FY2022 | Sep 30, 2022 | 904M | -0.8% |
| Q2 FY2022 | Jun 30, 2022 | 903M | -0.8% |
| Q1 FY2022 | Mar 31, 2022 | 906M | -0.7% |
| Q4 FY2021 | Dec 31, 2021 | 912M | -0.3% |
| Q3 FY2021 | Sep 30, 2021 | 911M | -0.1% |
| Q2 FY2021 | Jun 30, 2021 | 910M | -0.1% |
| Q1 FY2021 | Mar 31, 2021 | 912M | +0.1% |
| Q4 FY2020 | Dec 31, 2020 | 914M | -0.1% |
| Q3 FY2020 | Sep 30, 2020 | 911M | -0.8% |
| Q2 FY2020 | Jun 30, 2020 | 911M | -1.5% |
| Q1 FY2020 | Mar 31, 2020 | 912M | -7.3% |
| Q4 FY2019 | Dec 31, 2019 | 916M | -10.4% |
| Q3 FY2019 | Sep 30, 2019 | 919M | -10.5% |
| Q2 FY2019 | Jun 30, 2019 | 925M | -10.3% |
| Q1 FY2019 | Mar 31, 2019 | 984M | -6.3% |
| Q4 FY2018 | Dec 31, 2018 | 1.02B | -1.5% |
| Q3 FY2018 | Sep 30, 2018 | 1.03B | -2.8% |
| Q2 FY2018 | Jun 30, 2018 | 1.03B | -2.5% |
| Q1 FY2018 | Mar 31, 2018 | 1.05B | -0.6% |
| Q4 FY2017 | Dec 31, 2017 | 1.04B | -2.5% |
| Q3 FY2017 | Sep 30, 2017 | 1.06B | – |
| Q2 FY2017 | Jun 30, 2017 | 1.06B | – |
| Q1 FY2017 | Mar 31, 2017 | 1.06B | – |
| Q4 FY2016 | Dec 31, 2016 | 1.06B | – |
See a number that looks wrong?